We’re WinSanTor, a patient owned pharmaceutical company with a drug that aims to reverse peripheral neuropathy AMA!
We’re a patient owned pharmaceutical company with a drug that reverses peripheral neuropathy. Peripheral neuropathy is a is a neurodegenerative disease that affects nearly 1 in 15 people.
Peripheral neuropathy is a slow often unspoken, and definitely neglected, complication that arises from many other diseases: over half of all diabetics, nearly half of all cancer patients, a third of all HIV patients, and many from unknown causes. But many of you probably know all this.
Unfortunately, as many of you know, there are no treatments other than pain killers. Our drugs now appear to be reversing this disease, starting with the underlying biology, nerve regrowth, and then return of function and, most importantly, quality of life. We hope we are a new model for pharma – patient-centric. Not just in developing a drug that works, but safe, and transparently affordable. In fact, we are now patient owned. So, impact to patients – that is our goal.
We are Stanely Kim and Katie Frizzi—the CEO and Project Scientist for Winsantor. Ask us anything!
And check out some cool pictures on Twitter ! https://twitter.com/WinSanTor
Hey everyone! Thanks for all the questions. We are going to head out now but if you have anymore pressing questions or you'd like more information about our drug or our company please email us at: [[email protected]](mailto:[email protected])
Many of you are asking about our clinical studies. We will have several small studies in Canada, Europe and US for diabetic peripheral neuropathy in 2019. It will expand to other indications, financing/resource dependent. Find out more by signing up for our newsletter (biannually) at our website. Also help us by signing up for our survey (anonymous) to give us a sense of you and your condition